Potentiation of morphine-induced conditioned place preference with concurrent use of amantadine and fluvoxamine by the intraperitoneal and intracerebroventricular injection in rat

Behavioural Brain Research

Volumn 190, Issue 2, 2008, Pages 189-192

  Maleki, Saeid Abbasi ^a   Samini, Morteza ^b   Babapour, Vahab ^c   Mehr, Shahram Ejtemaei ^b   Cheraghiyan, Siyamak ^d   Nouri, Mir H Khayat ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d URMIA UNIVERSITY   (Iran)

Author keywords

Amantadine; Conditioned place preference; Fluvoxamine; i.c.v.; Morphine; Rat

Indexed keywords

AMANTADINE; DOPAMINE; FLUVOXAMINE; MORPHINE; MU OPIATE RECEPTOR; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; MALE; MORPHINE ADDICTION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; REINFORCEMENT; REWARD; SYNAPSE;

AMANTADINE; ANIMALS; ASSOCIATION LEARNING; BEHAVIOR, ANIMAL; CONDITIONING, CLASSICAL; DOPAMINE AGENTS; DRUG SYNERGISM; FLUVOXAMINE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MALE; MORPHINE; NARCOTICS; RATS; RATS, WISTAR; REWARD; SEROTONIN UPTAKE INHIBITORS;

EID: 42249105203     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.02.027     Document Type: Article

References (23)

1. Xi Z.X., and Stein EA. GABAergic mechanisms of opiate reinforcement. Alcohol Alcohol 37 5 (2002) 485-494
2. Cami J., and Farré M. Mechanism of disease, drug addiction. N Engl J Med 349 10 (2003) 975-986
3. Hughes A.L., and Nutt D. Neurobiology of addiction and implications for treatment. Br J Psychiatry 182 (2003) 97-100
4. Samini M., Kardan A., and Mehr S.E. Alpha-2 agonists decreases expression of morphine induced conditioned place preference. Pharm Biochem Behav 88 4 (2008) 403-406
5. Benloucif S., Keegan M.J., and Galloway M.P. Serotonin-facilitated dopamine release in vivo: pharmacological characterization. JPET 265 (1993) 373-377
6. Parsons L.H., and Justice Jr. J.B. Perfusate serotonin increase extracellular dopamine in the nucleus accumbens of the rat as measured by in vivo microdialysis. Brain Res 606 (1993) 195-199
7. Harris G.C., and Aston-Jones G. Involvement of D2 dopamine receptor in the nucleus accumbens in the opiate withdrawal syndrome. Nature 371 (1994) 155-157
8. Pothos E., Rada P., Mark G.P., and Hoebel B.G. Dopamine microdialysis in the nucleus acumbens during acute and chronic morphine, naloxone - precipitated withdrawal and clonidine treatment. Brain Res 566 (1991) 348-350
9. Huber T.J., Dietrich D.E., and Emrich H.M. Possible use of amantadine in depression. Pharmacopsychiatry 32 2 (1999) 47-55
10. Allers K.A., Bergstrom D.A., Ghazi L.J., Kreiss D.S., and Walters J.R. MK801 and amantadine exert different effects on subthalamic neuronal activity in a rodent model of Parkinson's disease. Exp Neurol 191 1 (2005) 104-118
11. Bibbiani F., Oh J.D., Kielaite A., Collins M.A., Smith C., and Chase T.N. Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD. Exp Neurol 196 2 (2005) 422-429
12. Biachi C., and Tomasi L. Central nervous system and autonomic nervous system effects of amantadine and some standard anti-Parkinson drugs. Pharmacology 10 (1973) 226-237
13. Stoof J.C., Booij J., and Drukarch B. Amantadine as N-methyl-d-aspartic acid receptor antagonist: new possibilities for therapeutic applications?. Clin Neurol Neurossurg 213 (1992) 439-443
14. Peeters M., Page G., Maloteaux J.M., and Hermans E. Hypersensitivity of dopamine transmission in the rat striatum after treatment with the NMDA receptor antagonist amantadine. Brain Res 949 1-2 (2002) 32-41
15. Samini M., Arefi H., and Shafaroodi H. Effects of fluoxetine and amantadine on naloxone precipitated morphine withdrawal signs in mice. APJP 16 2 (2004) 71-76
16. Schramm-Sapyta N.L. Drug addiction: what can animal models teach us?. Preclinica 2 6 (2004) 416-421
17. Aujla H., and Benineger R.J. Intra-accumbens protein kinase C inhibitor NPC 15437 blocks amphetamine - produced conditioned place preference in rats. Behav Brain Res 147 (2003) 41-48
18. Hsieh G.C., Hollingsworth P.R., Martino B., Chang R., Terranova M.A., O'Neill A.B., et al. Central mechanisms regulating penile erection in conscious rats: the dopaminergic system related to the pro-erectile effect of apomorphine. JPET 308 (2004) 303-338
19. Subhan F., Deslanddes P.N., Pache D.M., and Sewell R.D.E. Do antidepressants affect motivation in conditioned place preference?. Eur J Pharmacol 408 (2000) 257-263
20. Zarrindast M.R., Bahreini T., and Adl M. Effect of imipramine on the expression and acquisition on morphine-induced conditioned place preference in mice. Pharmacol Biochem Behav 73 (2002) 941-949
21. Tao R., and Auerbach S.B. GABAergic and glutamatergic afferents in the dorsal raphe nucleus mediate morphine-induced increase in serotonin efflux in the rat central nervous system. JPET 303 (2002) 704-710
22. Kalivas P.W., and Nakamura M. Neural system foe behavioral activation and reward. Curr Opin Neurobiol 9 (1999) 223-227
23. Nicola S.M., Surmeier D.J., and Malenka R.C. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev Neurosci 23 (2000) 185-215